WallStreetZenWallStreetZen

NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Bonnie L. BasslerDirector2024-03-281,240$30.23
$37.48kBuy
Henry A. FernandezDirector2024-03-281,240$30.23
$37.48kBuy
Rory B. RiggsDirector2024-01-0435,702$27.55
$983.52kSell
Rory B. RiggsDirector2024-01-03199,098$27.79
$5.53MSell
Rory B. RiggsDirector2024-01-02235,200$28.52
$6.71MSell
Henry A. FernandezDirector2023-12-291,353$27.71
$37.49kBuy
Avara Management LtdDirector2023-12-2965,803$28.04
$1.85MSell
Bonnie L. BasslerDirector2023-12-291,353$27.71
$37.49kBuy
Avara Management LtdDirector2023-12-28209,863$28.20
$5.92MSell
Avara Management LtdDirector2023-12-2741,729$28.01
$1.17MSell

1 of 4

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley7.76%46,354,266$1.29BInstitution
Adage Capital Partners GP LLC6.48%38,714,280$1.08BInsider
Vanguard Group Inc6.36%37,997,522$1.06BInstitution
Fmr LLC5.29%31,583,929$878.66MInstitution
1978 Sicaf Sif Sa 1. Gg3.70%22,081,156$614.30MInsider
Blackrock Inc3.59%21,459,462$597.00MInstitution
1978 Sicaf Sif Sa Gg3.59%21,426,170$596.08MInsider
Baillie Gifford Co2.94%17,590,450$489.37MInstitution
Adage Capital Partners GP LLC1.82%10,896,931$303.15MInstitution
Viking Global Investors LP1.69%10,087,417$280.63MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX51.02%16.51%Net SellingNet Buying
BMRN98.08%1.63%Net SellingNet Selling
ALNY80.88%19.12%Net SellingNet Selling
BGNE3.31%34.70%Net SellingNet Selling
GMAB70.53%0.00%
View Top Biotech Stocks

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 51.02% institutional shareholders, 16.51% Royalty Pharma insiders, and 32.47% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.48% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $1.08B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.